US11299507B2 - Synthesis and use of oxa-spirodiphosphine ligand - Google Patents

Synthesis and use of oxa-spirodiphosphine ligand Download PDF

Info

Publication number
US11299507B2
US11299507B2 US16/770,087 US201816770087A US11299507B2 US 11299507 B2 US11299507 B2 US 11299507B2 US 201816770087 A US201816770087 A US 201816770087A US 11299507 B2 US11299507 B2 US 11299507B2
Authority
US
United States
Prior art keywords
mmol
reaction
ligand
cdcl
nmr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
US16/770,087
Other languages
English (en)
Other versions
US20200308206A1 (en
Inventor
Xumu Zhang
Genqiang CHEN
Jiaming Huang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shenzhen Catalys Technology Co Ltd
Original Assignee
Shenzhen Catalys Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shenzhen Catalys Technology Co Ltd filed Critical Shenzhen Catalys Technology Co Ltd
Assigned to SHENZHEN CATALYS TECHNOLOGY CO., LTD reassignment SHENZHEN CATALYS TECHNOLOGY CO., LTD ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CHEN, Genqiang, HUANG, JIAMING, ZHANG, XUMU
Publication of US20200308206A1 publication Critical patent/US20200308206A1/en
Application granted granted Critical
Publication of US11299507B2 publication Critical patent/US11299507B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0046Ruthenium compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/22Organic complexes
    • B01J31/2204Organic complexes the ligands containing oxygen or sulfur as complexing atoms
    • B01J31/2208Oxygen, e.g. acetylacetonates
    • B01J31/2213At least two complexing oxygen atoms present in an at least bidentate or bridging ligand
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/24Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
    • B01J31/2404Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring
    • B01J31/2442Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring comprising condensed ring systems
    • B01J31/249Spiro-condensed ring systems
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/26Catalysts comprising hydrides, coordination complexes or organic compounds containing in addition, inorganic metal compounds not provided for in groups B01J31/02 - B01J31/24
    • B01J31/28Catalysts comprising hydrides, coordination complexes or organic compounds containing in addition, inorganic metal compounds not provided for in groups B01J31/02 - B01J31/24 of the platinum group metals, iron group metals or copper
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/36Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by hydrogenation of carbon-to-carbon unsaturated bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0046Ruthenium compounds
    • C07F15/0053Ruthenium compounds without a metal-carbon linkage
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/60Reduction reactions, e.g. hydrogenation
    • B01J2231/64Reductions in general of organic substrates, e.g. hydride reductions or hydrogenations
    • B01J2231/641Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes
    • B01J2231/645Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes of C=C or C-C triple bonds
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/80Complexes comprising metals of Group VIII as the central metal
    • B01J2531/82Metals of the platinum group
    • B01J2531/821Ruthenium
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Definitions

  • the present invention relates to the field of asymmetric catalysis, and particularly to the synthesis of a novel oxa-spirodiphosphine ligand.
  • the compound can be used as a chiral ligand in asymmetric catalytic reactions and has high potential of use in the field of asymmetric catalysis.
  • asymmetric catalysis has achieved rapid development.
  • Various chiral ligands have been synthesized and used in the field of asymmetric catalysis.
  • the diphosphine ligand is one of the ligands that are most widely used and extensively studied so far. It exhibits excellent activity and enantioselectivity in asymmetric hydrogenation, asymmetric hydroformylation, asymmetric Pauson-Khand reaction, asymmetric Heck reaction, asymmetric cycloaddition reaction, and asymmetric cycloisomerisation reaction, etc.
  • DIOP synthesized by the Kagan's team, BINAP developed by the Noyori's team, and DIPAMP ligand developed by the Knowles' team are milestones in the development history of diphosphine ligands. They have been widely used in academia and industry. Then various chiral diphosphine ligands were synthesized, for example, SegePhos, DifluoPhos, SynPhos, C n -TunePhos, TangPhos, DuanPhos, ZhangPhos, SKP, SDP, and SFDP.
  • the present invention provides an oxa-spirodiphosphine ligand having a structure of general Formula (I) below:
  • R 1 and R 2 are independently alkyl, alkoxy, aryl, aryloxy, or hydrogen, in which R 1 , R 2 , R 3 and R 4 may or may not form a ring; R 1 and R 6 are independently alkyl, aryl, or hydrogen; and R 1 and R 8 are alkyl, benzyl, or aryl.
  • alkyl is preferably methyl, ethyl, propyl, butyl, or the like.
  • alkoxy is preferably methoxy, ethoxy, propoxy, butoxy, or the like.
  • the aryl is preferably phenyl that is unsubstituted or substituted with alkyl or alkoxy as defined above.
  • the aryloxy is preferably methoxyphenyl, ethoxyphenyl or the like.
  • R 1 , R 2 , R 3 , R 4 , R 5 , and R 6 are all hydrogen.
  • the oxa-spirodiphosphine ligand is the ( ⁇ )-oxa-spirodiphosphine ligand, the (+)-oxa-spirodiphosphine ligand, or the ( ⁇ )-oxa-spirodiphosphine ligand.
  • the oxa-spirodiphosphine ligand is a compound having a structure below:
  • Ar is alkyl, benzyl or aryl; and most preferably Ar is phenyl, or phenyl substituted with alkyl or alkoxy.
  • alkyl and alkoxy are as defined above.
  • Another object of the present invention is to provide a method for synthesizing the compound by the following route:
  • Another object of the present invention is to provide use of the compound in catalyzing asymmetric reactions including hydrogenation reaction, hydroformylation reaction, hydrosilation reaction, hydroboration reaction, hydroxylation with hydrogen peroxide, hydroamination reaction, hydrocyanation reaction, isomerization and formylation reaction, hydroaminomethylation reaction, transfer hydrogenation reaction, allylation reaction, olefin metathesis reaction, cycloisomerization reaction, Diels-Alder reaction, asymmetric coupling reaction, Aldol reaction, Michael addition reaction, asymmetric epoxidation reaction, kinetic resolution and [m+n] cyclization reaction.
  • the diphosphine ruthenium acetate complex prepared from the compound has a high activity and an enantioselectivity of greater than 99% for the hydrogenation of unsaturated carboxylic acids in organic solvents.
  • diphosphine ruthenium acetate complex is a compound having a structure below:
  • R alkyl, fluoroalkyl or aryl; and alkyl and aryl as defined above are preferred.
  • the compound is used as a catalyst, and the reaction route is as follows:
  • R alkyl, fluoroalkyl or aryl; and preferably alkyl and aryl as defined above.
  • Another object of the present invention is to provide a bisphosphine ruthenium acetate complex, which has high activity and enantioselectivity for hydrogenation of unsaturated carboxylic acids in an organic solvent.
  • the bisphosphine ruthenium acetate complex is a compound shown below:
  • R alkyl, fluoroalkyl or aryl; and alkyl or aryl as defined above are preferred.
  • the oxa-spiro compound has central chirality, and thus include L-oxa-spirodiphosphine ligand and R-oxa-spirodiphosphine ligand.
  • the racemic spirodiphosphine ligand can be synthesized from racemic oxa-spirobisphenol as a raw material.
  • the present invention can be used as a chiral ligand in the asymmetric hydrogenation of unsaturated carboxylic acids. Its complex with ruthenium can achieve an enantioselectivity of greater than 99% in the asymmetric hydrogenation of methyl-cinnamic acid.
  • FIG. 1 is a schematic view showing the preparation of various chiral compounds according to the present invention, and the corresponding conversion rates and enantioselectivity ee.
  • the conversion rate of various substances in the presence of 6a is shown in FIG. 1 .

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
US16/770,087 2018-02-08 2018-02-08 Synthesis and use of oxa-spirodiphosphine ligand Active US11299507B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2018/075860 WO2019153203A1 (fr) 2018-02-08 2018-02-08 Synthèse et application d'un ligand oxaspirocyclodiphosphine

Publications (2)

Publication Number Publication Date
US20200308206A1 US20200308206A1 (en) 2020-10-01
US11299507B2 true US11299507B2 (en) 2022-04-12

Family

ID=67548677

Family Applications (1)

Application Number Title Priority Date Filing Date
US16/770,087 Active US11299507B2 (en) 2018-02-08 2018-02-08 Synthesis and use of oxa-spirodiphosphine ligand

Country Status (4)

Country Link
US (1) US11299507B2 (fr)
EP (1) EP3730502B1 (fr)
ES (1) ES3005385T3 (fr)
WO (1) WO2019153203A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220185835A1 (en) * 2020-06-05 2022-06-16 Shenzhen Catalys Technology Co., Ltd Synthesis and use of oxa-spirodiphosphine ligand

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115304617A (zh) * 2021-05-08 2022-11-08 惠州凯特立斯科技有限公司 一种大位阻氧杂螺环二酚及其双膦配体的合成方法
CN115724781A (zh) * 2021-08-30 2023-03-03 凯特立斯(深圳)科技有限公司 一种合成乌帕替尼关键手性中间体的方法
CN116655693A (zh) * 2023-04-28 2023-08-29 凯特立斯(深圳)科技有限公司 氧杂螺环双膦配体的制备方法及其应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210340168A1 (en) * 2020-04-30 2021-11-04 Shenzhen Catalys Technology Co., Ltd. OXA-SPIRODIPHOSPHINE LIGAND AND METHOD FOR ASYMMETRIC HYDROGENATION OF alpha, beta-UNSATURATED CARBOXYLIC ACIDS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1238361C (zh) * 2003-02-21 2006-01-25 南开大学 螺环双膦配体
CN1562926A (zh) * 2004-04-14 2005-01-12 南开大学 新型螺环双膦配体及其在不对称催化氢化中的应用
JP5454756B2 (ja) * 2008-08-26 2014-03-26 国立大学法人 千葉大学 ジホスフィン化合物、その遷移金属錯体およびその遷移金属錯体を含む触媒並びにホスフィンオキシド化合物及びジホスフィンオキシド化合物
WO2017135897A1 (fr) * 2016-02-02 2017-08-10 Agency For Science, Technology And Research Catalyseur pour la carbonylation d'alcènes

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210340168A1 (en) * 2020-04-30 2021-11-04 Shenzhen Catalys Technology Co., Ltd. OXA-SPIRODIPHOSPHINE LIGAND AND METHOD FOR ASYMMETRIC HYDROGENATION OF alpha, beta-UNSATURATED CARBOXYLIC ACIDS

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
American Chemical Society Chemical Abstract Service. RN 2305757-36-0, entered into STN/first available to public on Apr. 29, 2019. (Year: 2019). *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220185835A1 (en) * 2020-06-05 2022-06-16 Shenzhen Catalys Technology Co., Ltd Synthesis and use of oxa-spirodiphosphine ligand
US12071444B2 (en) * 2020-06-05 2024-08-27 Shenzhen Catalys Technology Co., Ltd Synthesis and use of oxa-spirodiphosphine ligand

Also Published As

Publication number Publication date
US20200308206A1 (en) 2020-10-01
EP3730502B1 (fr) 2024-10-02
WO2019153203A1 (fr) 2019-08-15
EP3730502A1 (fr) 2020-10-28
ES3005385T3 (en) 2025-03-14
EP3730502A4 (fr) 2021-02-24

Similar Documents

Publication Publication Date Title
CN110128471B (zh) 氧杂螺环双膦配体的合成与应用
Schwink et al. New C2-symmetrical ferrocenyl diamines as ligands for ruthenium catalyzed transfer hydrogenation
US11299507B2 (en) Synthesis and use of oxa-spirodiphosphine ligand
EP1451133B1 (fr) Phospholanes p chiraux et composes phosphocycliques et leur utilisation dans des reactions catalytiques asymetriques
US7589218B2 (en) Chiral spiro compounds and their use in asymmetric catalytic reactions
KR100384411B1 (ko) 키랄리간드인헤테로방향족디포스핀
Asami et al. Enantioselective addition of dialkylzinc to aldehydes catalyzed by (S)-2-(N, N-disubstituted aminomethyl) indoline
CN100410234C (zh) 利用手性布朗斯台德酸的不对称合成用催化剂和使用该催化剂的不对称合成方法
Kuwano et al. A trans-chelating bisphosphine possessing only planar chirality and its application to catalytic asymmetric reactions
US7169953B2 (en) P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions
US6380392B1 (en) Ligands based on chiral 2-amino-2′-hydroxy-1,1′-binaphthyl and related frameworks for asymmetric catalysis
US7169938B2 (en) Process for preparing arylaminopropanols
CN105152934B (zh) 催化不对称合成轴手性联芳基二酚的方法
CN112279743B (zh) 一种手性α-氨基酸酯衍生物的合成方法
US6362344B1 (en) Catalysts for asymmetric addition of organozinc regents to aldehydes and method for preparation
US12071444B2 (en) Synthesis and use of oxa-spirodiphosphine ligand
FR2789992A1 (fr) Procede de preparation de diphosphines chirales utiles comme ligands dans la synthese de complexes destines a la catalyse asymetrique
CN110128472B (zh) 一种氧杂螺环pnn类型配体的合成与应用
US7718831B2 (en) Method for asymmetric hydrosilylation of ketones
US7649117B2 (en) Process of preparing optically active β-hydroxycarboxylic acid derivative
US20050014633A1 (en) Biphenyldiphosphine compounds
US9527862B2 (en) Compounds of chiral aromatic spiroketal diphosphine ligands, preparation methods and uses thereof
US6288268B1 (en) Catalyst for bisalkoxycarbonylation of olefins, and method for production of succinate derivatives
Shen et al. Asymmetric Alkynylation of Aldehydes Catalyzed by Bifunctional Zinc (salen) Complex
JP2015172024A (ja) 水素結合形成アミド基を持つキラル二環式ジエン配位子

Legal Events

Date Code Title Description
AS Assignment

Owner name: SHENZHEN CATALYS TECHNOLOGY CO., LTD, CHINA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ZHANG, XUMU;CHEN, GENQIANG;HUANG, JIAMING;REEL/FRAME:052852/0174

Effective date: 20200513

FEPP Fee payment procedure

Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

FEPP Fee payment procedure

Free format text: ENTITY STATUS SET TO SMALL (ORIGINAL EVENT CODE: SMAL); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS

STPP Information on status: patent application and granting procedure in general

Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT VERIFIED

STCF Information on status: patent grant

Free format text: PATENTED CASE

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2551); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

Year of fee payment: 4